N/A
Completed N=117
SUPER Study (Substance Use and PTSD Treatment Effectiveness Research Study)
Source: ClinicalTrials.gov NCT00265564 ↗Enrolled (actual)
117
Serious AEs
0.0%
Results posted
Sep 2020
Primary outcomePrimary: Severity of Alcohol Use (ASI Alcohol Composite Scores) — .259; .225; .169; .152 units on a scale — p=> .05
Summary
This study proposes a prospective program of research that will identify feasible and inexpensive methods to detect and treat comorbid PTSD among VA SUD patients, thereby improving substance abuse treatment outcomes.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Severity of Alcohol Use (ASI Alcohol Composite Scores) |
.259; .225; .169; .152; .138; .141 | > .05 |
| PRIMARY ASI Drug Composite Score |
.089; .106; .057; .095; .051; .088 | <.05 sig |
| SECONDARY PTSD Symptoms (IES Total Score) |
46.76; 47.66; 40.80; 42.40; 38.90; 36.47 | >.05 |
Eligibility Criteria
Inclusion Criteria
- veteran status and VA healthcare eligibility,
- a diagnosis of any alcohol or drug use disorder,
- having completed an intake for outpatient SUD treatment at the VA Oakland outpatient mental health clinic, and
- meeting criteria for a PTSD diagnosis based on a preliminary screen with the PC-PTSD and subsequent full clinical evaluation using the CAPS
Exclusion Criteria
- current participation in any day or inpatient mental health treatment,
- any contraindications communicated by that patient's primary clinician,
- acute psychosis, mania, dementia, or suicidal intent
Data sourced from ClinicalTrials.gov (NCT00265564). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.